Related Experiment Video
Updated: Jun 5, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
Published on: February 8, 2019
Giant cell arteritis: laboratory predictors of a positive temporal artery biopsy
Matthew D Walvick1, Michael P Walvick
1PGY-2 Internal Medicine, University of California San Francisco-Fresno, Fresno, California 93701, USA. mwalvick@gmail.com
Insights
C-reactive protein (CRP) and thrombocytosis are significant predictors of a positive temporal artery biopsy in giant cell arteritis. Elevated CRP and platelet counts are more strongly associated with positive biopsies than erythrocyte sedimentation rate.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Giant cell arteritis (GCA) is a systemic vasculitis affecting large and medium-sized arteries.
- Temporal artery biopsy (TAB) is a key diagnostic tool for GCA.
- Identifying reliable predictors of a positive TAB is crucial for timely diagnosis and treatment.
Purpose of the Study:
- To identify laboratory predictors associated with a positive temporal artery biopsy.
- To evaluate the predictive value of erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and platelet count for GCA diagnosis.
Main Methods:
- Retrospective cross-sectional study utilizing electronic health records from 1997-2006.
- Analysis of 3001 patients who underwent TAB.
- Calculation of odds ratios for ESR, CRP, and platelet count in relation to positive TAB results.
Main Results:
- A positive TAB was associated with an erythrocyte sedimentation rate (ESR) between 47-107 mm/hr (OR 1.5).
- A C-reactive protein (CRP) level >2.45 mg/dL increased the odds of a positive TAB by 5.3 times.
- Platelet count >400,000/μL was associated with 4.2 times greater odds of a positive TAB.
Conclusions:
- CRP levels >2.45 mg/dL are significant predictors of a positive TAB in GCA.
- CRP and thrombocytosis (elevated platelet count) appear to be stronger predictors of a positive TAB than ESR.
- These findings support the utility of CRP and platelet count in the diagnostic workup of suspected GCA.
Purpose:
To identify laboratory predictors of a positive temporal artery biopsy.
Design:
Cross-sectional study using retrospective electronic data base review.
Participants:
There were 3001 patients who had a temporal artery biopsy.
Methods:
The electronic database of a large health maintenance organization was searched for all patients who had a temporal artery biopsy performed from 1997 to 2006.
Main Outcome Measures:
Odds ratios for erythrocyte sedimentation rate, C-reactive protein (CRP), and platelet count values associated with a positive temporal artery biopsy.
Results:
Four hundred fifty-nine cases of biopsy-proven giant cell arteritis were identified. The odds of a positive biopsy were 1.5 times greater with an erythrocyte sedimentation rate of 47 to 107 mm/hr, 5.3 times greater with a CRP >2.45 mg/dL, and 4.2 times greater with platelets >400,000/μL.
Conclusions:
In this largest population-based giant cell arteritis study in the United States to date, we reaffirm Hayreh's finding of the significance of a CRP level >2.45 mg/dL in predicting a positive biopsy. Our findings support the literature suggesting that CRP and thrombocytosis may be stronger predictors of positive biopsy than erythrocyte sedimentation rate.
Financial Disclosure(S):
The authors have no proprietary or commercial interest in any of the materials discussed in this article.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Assessing Body Temperature - Temporal Artery
Step 1: Perform hand hygiene and don a fresh pair of gloves to prevent cross-infection and ensure patient safety.
Step 2: Explain the procedure to the patient to establish trust. Clear communication establishes trust with the patient, ensures they understand what to expect, promotes cooperation, and enhances comfort during the procedure.
Step 3: Assess the patient's forehead...
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests